Michael Nally

Chief Executive Officer

Michael Nally (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in GENB. Across 1 priced purchase filing, the average 21-session return was +7.3% from execution and -1.9% from disclosure (delay-adjusted; derived). The largest single filing was $240K of GENB (20,000 sh × $12.00, as filed), executed Mar 4.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+7.3%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-1.9%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$240K

shares × price, as filed

Last traded

Mar 4

Filed Mar 6

Open performance→

Volume by month

Buys $240K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names

GENB GENB GENB · 1 buy · 0 sells 1 filing

Recent filings

GENBPURCHASE Generate Biomedicines, Inc. View filing → $240K
20,000 sh × $12.00
Exec Mar 4
Filed Mar 6 · 4:55 PM ET